Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fabian Bull"'
Autor:
Giang T. H. Vu, Thomas Schmutzer, Fabian Bull, Hieu X. Cao, Jörg Fuchs, Trung D. Tran, Gabriele Jovtchev, Klaus Pistrick, Nils Stein, Ales Pecinka, Pavel Neumann, Petr Novak, Jiri Macas, Paul H. Dear, Frank R. Blattner, Uwe Scholz, Ingo Schubert
Publikováno v:
The Plant Genome, Vol 8, Iss 3 (2015)
The C-value paradox remains incompletely resolved after >40 yr and is exemplified by 2,350-fold variation in genome sizes of flowering plants. The carnivorous Lentibulariaceae genus , displaying a 25-fold range of genome sizes, is a promising subject
Externí odkaz:
https://doaj.org/article/c1838783b6904b898506a4f5c8f20291
Autor:
Norbert Nass, Johannes Haybaeck, Ivo Grosse, Esra Özdemir, Atanas Ignatov, Sebastian Graf, Katrin Hoffmann, Thomas Kalinski, Martin Porsch, Martin Wisniewski, Fabian Bull
Acquired tamoxifen resistance is a persistent problem for the treatment of estrogen receptor positive, premenopausal breast cancer patients and predictive biomarkers are still elusive. We here analyzed gene expression changes in a cellular model to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f438ccb9ff6a86227283f66226de18b8
https://europepmc.org/articles/PMC6546408/
https://europepmc.org/articles/PMC6546408/
Autor:
Petr Novák, Nils Stein, Paul H. Dear, Ales Pecinka, Trung Dinh Tran, Uwe Scholz, Gabriele Jovtchev, Fabian Bull, Giang Thu Vu, Pavel Neumann, Joerg Fuchs, Thomas Schmutzer, Klaus Pistrick, Hieu X. Cao, Jiří Macas, Frank R. Blattner, Ingo Schubert
Publikováno v:
The Plant Genome, Vol 8, Iss 3 (2015)
Plant Genome
Plant Genome
The C-value paradox remains incompletely resolved after >40 yr and is exemplified by 2,350-fold variation in genome sizes of flowering plants. The carnivorous Lentibulariaceae genus Genlisea, displaying a 25-fold range of genome sizes, is a promising
Autor:
Ulrich Wuellner, Kristina Klupsch, Fabian Buller, Isabella Attinger-Toller, Roger Santimaria, Irene Zbinden, Patricia Henne, Dragan Grabulovski, Julian Bertschinger, Simon Brack
Publikováno v:
Antibodies, Vol 4, Iss 4, Pp 426-440 (2015)
CD3 bispecific therapies retargeting T cells to tumors have recently demonstrated striking activity in patients. Several CD3 bispecific antibodies directed against various tumor targets are currently being investigated in the clinic across different
Externí odkaz:
https://doaj.org/article/ace5b95010614b2c9dd9d0be87c5386d